Avisit to the optometrist is not just about refractive correction
and for many, ocular discomfort due to allergies is also a big concern.
Allergic conjunctivitis (AC) is a common form of eye irritation due to the body’s response to certain allergens on the optic surface.
Grasses, trees and family pets can contribute to AC, which becomes more difficult to treat if the individual uses contact lenses.
Although many topical treatments are currently on the market, Johnson & Johnson Vision (Jacksonville, Florida, USA)
has introduced an exciting new product that may offset the woes brought on by AC: the world’s first ลาวสามัคคี วีไอพี
and only drugreleasing combination contact lens for vision correction and allergic eye itch: ACUVUE® Theravision™ with Ketotifen.
This new product uses the already trusted ACUVUE technology with antihistamines in order to combat eye irritation.
The science behind the lens Ocular itch due to allergies is one of the most common ailments contact users face.
A 2019 study* described the most common cause of AC is from the presence of allergens.
The authors said: “The itch response is due to conjunctival mast-cell release of histamine and other inflammatory mediators.”
Many topical treatments have been developed i
n order to treat this problem such as antihistamines including: olopatadine, bepotastine or ketotifen.
The study described these treatments as “second-generation antihistamines are characterized by a rapid, prolonged suppression of allergen-associated itch responses.”
In order to combat itchy eyes, many patients choose to use topical treatments that block overactive inflammatory responses.
However, topical treatments are far from perfect. Often contact lenses need to be removed to apply topical drops and there are concerns regarding the impact they might have on the durability of the contact lens.
Luckily, we now have a product that will make itchy eye relief much easier.
A new lens arrives In March 2021, Johnson & Johnson announced approval from the Japanese Ministry of Health, Labour and Welfare (MHLW) for these novel lenses.
This was followed by an April 2021 announcement that the company received approval
by Health Canada for these first-ever daily disposable contact lenses.
For more information: ลาวสามัคคี วีไอพี